Hyundai Bioscience Co. Ltd (048410) — Cash Flow Reinvestment Rate
Hyundai Bioscience Co. Ltd (048410) has a Cash Flow Reinvestment Rate of 1.11x as of December 2024, reinvesting ₩2.52 Billion (capex ₩2.17 Billion plus investments ₩-345.74 Million) from operating cash flow of ₩2.26 Billion. Explore Hyundai Bioscience Co. Ltd (048410) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hyundai Bioscience Co. Ltd Cash Flow Reinvestment Rate (2008–2024)
Historical reinvestment intensity for Hyundai Bioscience Co. Ltd across 8 annual periods. Also explore balance sheet size of Hyundai Bioscience Co. Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hyundai Bioscience Co. Ltd (2008–2024)
Year-by-year capital reinvestment analysis for Hyundai Bioscience Co. Ltd. For live market cap and broader valuation context, see Hyundai Bioscience Co. Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 9.71x | ₩21.91 Billion | ₩2.26 Billion | ₩2.17 Billion | ▲ +178.5% |
| 2020 | 3.49x | ₩26.15 Billion | ₩7.50 Billion | ₩25.20 Billion | ▲ +433.9% |
| 2019 | 0.65x | ₩5.99 Billion | ₩9.18 Billion | ₩3.07 Billion | ▼ -67.3% |
| 2018 | 2.00x | ₩9.99 Billion | ₩5.01 Billion | ₩7.07 Billion | ▼ -95.2% |
| 2015 | 41.75x | ₩3.65 Billion | ₩87.36 Million | ₩647.57 Million | ▲ +3034.7% |
| 2014 | 1.33x | ₩1.63 Billion | ₩1.22 Billion | ₩840.18 Million | ▲ +1874.4% |
| 2011 | 0.07x | ₩267.78 Million | ₩3.97 Billion | ₩267.78 Million | ▼ -82.1% |
| 2008 | 0.38x | ₩3.92 Billion | ₩10.37 Billion | ₩3.92 Billion | — |